CD4 and tuberculosis: We found that the patients who were lost to follow up were similar (p>0.05) to those who could be followed up in terms of their CD4 count, type of TB, category of TB and timing of initiation of ATT and ART which are the possible factors determining treatment outcomes as reported in this study.